Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BioAge Labs (BIOA) Equity Ratio (2023 - 2026)

BioAge Labs' Equity Ratio history spans 3 years, with the latest figure at 0.92 for Q4 2025.

  • On a quarterly basis, Equity Ratio rose 2.28% to 0.92 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.92, a 2.28% increase, with the full-year FY2025 number at 0.92, up 2.28% from a year prior.
  • Equity Ratio hit 0.92 in Q4 2025 for BioAge Labs, up from 0.91 in the prior quarter.
  • Over the last five years, Equity Ratio for BIOA hit a ceiling of 0.93 in Q3 2024 and a floor of 6.69 in Q4 2023.
  • Historically, Equity Ratio has averaged 0.17 across 3 years, with a median of 0.91 in 2025.
  • Biggest five-year swings in Equity Ratio: soared 113.49% in 2024 and later fell 2.2% in 2025.
  • Tracing BIOA's Equity Ratio over 3 years: stood at 6.69 in 2023, then soared by 113.49% to 0.9 in 2024, then increased by 2.28% to 0.92 in 2025.
  • Business Quant data shows Equity Ratio for BIOA at 0.92 in Q4 2025, 0.91 in Q3 2025, and 0.92 in Q2 2025.